Protein Alternatives (@ProAlt2006) header
Protein Alternatives (@ProAlt2006) profile picture

ProAlt is a biotechnological company focused on the development and commercialization of biomarker-based assays for cancer diagnosis and clinical management.

Community of Madrid, Spain
Joined March 2017
🔬 La semana pasada, PROALT patrocinó en la @urjc el evento “Hacia la medicina de precisión en cáncer de colon”, con participación de Custodia García Jiménez, José Manuel González Sancho, Rocío Díaz Sánchez, Natalia Pendás Franco y nuestro CEO, Juan Ignacio Imbaud. 👉
96
🚀 Protein Alternatives will be be presenting at #BioTrinity2025 in Science Track 1! 📅 April 2 | 🕝 14:30-16:00 🔬 Science Spotlight Thirteen – New Platforms & Technologies for Drug Discovery See you in London! ✨ #DrugDiscovery #Biotech #Innovation #ProteinAlternatives
14
Protein Alternatives Welcomes Dr Antoni Castells Garangou, MD, PhD, to our Scientific Advisory Board proteinalternatives.com/prot… #Welcome #Oncology #ProteinAlternatives
12
Protein Alternatives Welcomes Prof. Eric Van Cutsem, MD, PhD, to our Scientific Advisory Board proteinalternatives.com/prot… #Welcome #Oncology #ProteinAlternatives
12
Protein Alternatives welcomes back Hugo Cartagena in his new role as COO proteinalternatives.com/prot… #WelcomeBack #Biotechnology #ProteinAlternatives
16
ProAlt was selected by the European Innovation Council (@EUeic) to participate in the EIC Corporate Day with Merck (@merckgroup)
1
3
Protein Alternatives testará anticuerpos monoclonales frente al motivo RGD como un nuevo enfoque para el tratamiento de la COVID-19 linkedin.com/feed/update/urn… #COVID19 #SARSCoV2 #coronavirus #Antibodies
Anti RGD-motif monoclonal antibodies in development by Protein Alternatives (Proalt) will be tested as a new approach to treat COVID-19 linkedin.com/feed/update/urn… #COVID19 #SARSCoV2 #coronavirus #antibodies
2
6
#WorldCancerDay PROALT: Colorectal cancer diagnostic and therapeutic antibodies.